Ignite Creation Date:
2024-05-06 @ 8:22 AM
Last Modification Date:
2024-10-26 @ 11:59 AM
Study NCT ID:
NCT02728219
Status:
COMPLETED
Last Update Posted:
2016-04-05
First Post:
2016-03-28
Brief Title:
Comparison of Treatment of Recurrent HCC With Repeat Hepatectomyand TACE With AFP Conversion
Sponsor:
Eastern Hepatobiliary Surgery Hospital
Organization:
Eastern Hepatobiliary Surgery Hospital
Study Overview
Official Title:
A Prospective Randomized Trial Comparing Treatment of Recurrent HCC With Repeat Hepatectomyand Transcatheter Arterial Chemoembolization TACE With AFP Conversion
Status:
COMPLETED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HCCTACEAFP
Brief Summary:
The purpose of this study is to compare the treatment of recurrent hepatocellular carcinoma with repeat hepatectomyand transcatheter arterial chemoembolization TACE with AFP conversion
Detailed Description:
Though many HCC patients have been benefited from hepatectomy treatment still the high recurrence rate after the hepatectomy led to limited effectiveness
This is the first study in same case system on comparison of effectiveness among repeat hepatectomy and TACE with AFP conversion
This is the first study in same case system on comparison of effectiveness among repeat hepatectomy and TACE with AFP conversion
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None